Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Rxsight Inc
(NQ:
RXST
)
61.68
+2.05 (+3.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
532,855
Open
60.00
Bid (Size)
59.50 (2)
Ask (Size)
97.34 (2)
Prev. Close
59.63
Today's Range
59.59 - 61.85
52wk Range
18.09 - 61.85
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
RxSight, Inc. to Present at the Bank of America Healthcare Conference
May 01, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
April 22, 2024
From
RxSight, Inc.
Via
GlobeNewswire
Performance
YTD
+68.29%
+68.29%
1 Month
+20.37%
+20.37%
3 Month
+30.57%
+30.57%
6 Month
+155.19%
+155.19%
1 Year
+240.40%
+240.40%
More News
Read More
Assessing RxSight: Insights From 8 Financial Analysts
April 11, 2024
Via
Benzinga
RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
April 04, 2024
From
RxSight, Inc.
Via
GlobeNewswire
Forecasting The Future: 9 Analyst Projections For RxSight
February 29, 2024
Via
Benzinga
Recap: RxSight Q4 Earnings
February 28, 2024
Via
Benzinga
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
March 27, 2024
From
RxSight, Inc.
Via
GlobeNewswire
Chart Of The Day: RxSight - Cashing In On Cataracts
March 04, 2024
Via
Talk Markets
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
February 29, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
February 28, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight's Earnings Outlook
February 27, 2024
Via
Benzinga
Stifel Maintains Buy Rating for RxSight: Here's What You Need To Know
February 12, 2024
Via
Benzinga
The Analyst Landscape: 8 Takes On RxSight
January 29, 2024
Via
Benzinga
Earnings Scheduled For February 28, 2024
February 28, 2024
Via
Benzinga
Breaking Down RxSight: 5 Analysts Share Their Views
January 08, 2024
Via
Benzinga
Analyst Expectations for RxSight's Future
December 13, 2023
Via
Benzinga
RxSight: Q3 Earnings Insights
November 09, 2023
Via
Benzinga
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
February 14, 2024
From
RxSight, Inc.
Via
GlobeNewswire
Insiders are selling these hot stocks on track for higher prices
February 07, 2024
Via
MarketBeat
Jim Cramer: This Healthcare Stock Is 'Too Risky,' But Shares Jumped 64% Over Past Month
January 25, 2024
Via
Benzinga
3 Stocks to Buy BEFORE They Become Household Names
January 12, 2024
Via
InvestorPlace
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 08, 2024
Via
Benzinga
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
January 07, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
December 27, 2023
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. Reports Third Quarter 2023 Financial Results
November 09, 2023
From
RxSight, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.